Show simple item record

COST-UTILITY ANALYSIS OF IMMUNE TOLERANCE INDUCTION (ITI) THERAPY VERSUS ON-DEMAND TREATMENT WITH RECOMBINANT FVII (RFVIIA) FOR HEMOPHILIA A WITH HIGH TITER INHIBITORS IN IRAN

dc.contributor.authorImani, A
dc.contributor.authorRasekh, H
dc.contributor.authorGolestani, M
dc.date.accessioned2018-08-26T08:04:20Z
dc.date.available2018-08-26T08:04:20Z
dc.date.issued2012
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/49539
dc.language.isoEnglish
dc.relation.ispartofVALUE IN HEALTH
dc.titleCOST-UTILITY ANALYSIS OF IMMUNE TOLERANCE INDUCTION (ITI) THERAPY VERSUS ON-DEMAND TREATMENT WITH RECOMBINANT FVII (RFVIIA) FOR HEMOPHILIA A WITH HIGH TITER INHIBITORS IN IRAN
dc.typeMeeting Abstract
dc.citation.volume15
dc.citation.issue7
dc.citation.spageA680
dc.citation.epageA680
dc.citation.indexWeb of science
dc.identifier.DOIhttps://doi.org/10.1016/j.jval.2012.08.461


Files in this item

Thumbnail
Name:
1-s2.0-S1098301512021742-main.pdf
Size:
54.07Kb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record